The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis
Abstract Background Retinopathy of prematurity (ROP) is typically treated with laser photocoagulation and/or intravitreal anti-vascular endothelial growth factor (anti-VEGF). To the best of our knowledge, most systematic reviews have focused on comparing anti-VEGF against laser treatment while compa...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2023-10-01
|
| Colección: | Italian Journal of Pediatrics |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s13052-023-01543-3 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|